Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
N Mohammad1, O Darweesh2, M Merkhan3
11Department of Pharmacy, Al-Qalam University College, Kirkuk, Iraq.

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
03:42Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
PubMed で要約を見る
疾患変異薬との併用療法により,心不全性疾患 (IHD) の患者における脂質パラメータが著しく低下します. このアプローチは,心筋梗塞 (MI) や脳卒中などの心筋梗塞のリスク要因を管理するための貴重な戦略を提供します.
科学分野:
背景:
研究 の 目的:
主な方法:
主要な成果:
結論: